Skip to content

GH Research

US · GHRS #2969 by market cap Listed 2021
17.53 -1.03 -5.55%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

About GH Research

GH Research Plc is a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients with psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Sch?nharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.

Founded
2021
CEO
Dr. Velichka Valcheva, M.D.,M.Sc.
Employees
73
Headquarters
Dublin, Dublin, Ireland
Fiscal year end
12-31
Website
ghres.com

Company profile

Exchange
US
Symbol
GHRS
Market-cap rank
#2969
Listing date
2021-06-25
Market cap
1.20B
Float cap
590.64M
Shares out
68.68M
Float shares
33.69M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.

GH Research discussion 0 comments

Add a comment